REPORTS
 
 

Why do life sciences deals fail? Insights from industry dealmakers

This report, based on interviews with life sciences dealmaking veterans, looks at key risk factors for buyers and sellers in life sciences deals - ...

M&A and financing in the European renewable energy sector

This report looks at how the renewable energy sector has fared since the outbreak of the Covid-19 pandemic, and the challenges of investing in an ...

Report: 2022 Annual M&A Success Survey

Over the past year, companies have confronted several new challenges in an already highly complex deal environment. Global economic activity is ...

The impact of the war in Ukraine on pharmaceutical clinical trials

Both Ukraine and Russia are major centres for international clinical research, with many multinational pharmaceutical clinical trials taking place in ...

Preparing for net zero: How climate & sustainability will affect diligence in M&A Transactions

As the world heads towards net zero, this report examines the role climate change and sustainability will play in due diligence, including:

Phama Transactions: How resilient were they in the COVID-19 pandemic?

Hear from the former Head of Business Operations of AstraZeneca, John Easton as he explores the predictions of M&A deal flow during the COVID-19 ...

The Impact of the Annulled Privacy Shield

Green Deals: The role of sustainability in M&A

COVID-19, global lockdowns and the resultant economic downturn are changing how we do business. The emergency stop executed by the global economy has ...

Renewable Energy: What works and what's on the way?

Wind and solar are fast-becoming the renewable energies of choice in countries across the globe. But both of these resources still require ...